Ocumetics Technology Corp. (OTCFF)
USD 0.24
(0.0%)
USD 0.24
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 85.81 Thousand CAD | 127.7% |
| 2022 | -309.74 Thousand CAD | -269.18% |
| 2021 | -83.9 Thousand CAD | 62.6% |
| 2020 | -224.34 Thousand CAD | 14.01% |
| 2019 | -260.89 Thousand CAD | 13.16% |
| 2018 | -300.42 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 212.12 Thousand CAD | 147.2% |
| 2023 FY | 85.81 Thousand CAD | 127.7% |
| 2023 Q4 | 85.81 Thousand CAD | 191.29% |
| 2023 Q3 | -93.99 Thousand CAD | -144.15% |
| 2023 Q1 | -389.07 Thousand CAD | -25.61% |
| 2023 Q2 | 212.92 Thousand CAD | 154.72% |
| 2022 Q3 | -1.01 Million CAD | 12.5% |
| 2022 Q2 | -1.15 Million CAD | 20.97% |
| 2022 Q1 | -1.46 Million CAD | 20.37% |
| 2022 Q4 | -309.74 Thousand CAD | 69.48% |
| 2022 FY | -309.74 Thousand CAD | -269.18% |
| 2021 Q4 | -1.84 Million CAD | 11.77% |
| 2021 FY | -83.9 Thousand CAD | 62.6% |
| 2021 Q3 | -2.08 Million CAD | -1226.29% |
| 2021 Q1 | -202.67 Thousand CAD | 9.66% |
| 2021 Q2 | -157.5 Thousand CAD | 22.29% |
| 2020 Q3 | 840.00 CAD | 200.0% |
| 2020 Q4 | -224.34 Thousand CAD | -26807.86% |
| 2020 Q2 | -840.00 CAD | 0.0% |
| 2020 FY | -224.34 Thousand CAD | 14.01% |
| 2019 FY | -260.89 Thousand CAD | 13.16% |
| 2018 FY | -300.42 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 82.109% |
| Ansell Limited | -54.99 Million USD | 100.156% |
| Ansell Limited | -55.1 Million USD | 100.156% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 100.235% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 181.645% |
| Psykey, Inc. | 634.59 Thousand USD | 86.478% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.993% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.993% |
| Encision Inc. | 1.29 Million USD | 93.352% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 96.283% |
| Innovative MedTech Inc. | 1.76 Million USD | 95.137% |
| LifePoint, Inc. | -3.26 Million USD | 102.629% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 98.25% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 96.031% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 298.16% |
| Reflect Scientific, Inc. | -1.03 Million USD | 108.288% |
| SmileDirectClub, Inc. | 778.67 Million USD | 99.989% |
| Sector 10, Inc. | 163 Thousand USD | 47.355% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.021% |
| SheerVision, Inc. | 57.34 Thousand USD | -49.629% |
| United Health Products, Inc. | 660.56 Thousand USD | 87.01% |
| Vasamed, Inc. | 22.12 Thousand USD | -287.899% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 96.739% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 88.889% |